Pfizer/BioNTech say Omicron-based COVID shots improve response vs that variant
By Michael Erman NEW YORK – Pfizer Inc and BioNTech
By Michael Erman NEW YORK – Pfizer Inc and BioNTech
-Pfizer Inc and its German partner BioNTech SE on Tuesday
SAN JUAN, Puerto Rico – Liz Ann Banchs, the owner